VENTOLIN HFA Drug Patent Profile
✉ Email this page to a colleague
When do Ventolin Hfa patents expire, and when can generic versions of Ventolin Hfa launch?
Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA. There are two patents protecting this drug.
This drug has twenty-nine patent family members in seventeen countries.
The generic ingredient in VENTOLIN HFA is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-one suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ventolin Hfa
A generic version of VENTOLIN HFA was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.
Summary for VENTOLIN HFA
International Patents: | 29 |
US Patents: | 2 |
Applicants: | 1 |
NDAs: | 1 |
Finished Product Suppliers / Packagers: | 9 |
Raw Ingredient (Bulk) Api Vendors: | 71 |
Clinical Trials: | 47 |
Patent Applications: | 5,851 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for VENTOLIN HFA |
Drug Sales Revenues: | Drug sales revenues for VENTOLIN HFA |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for VENTOLIN HFA |
What excipients (inactive ingredients) are in VENTOLIN HFA? | VENTOLIN HFA excipients list |
DailyMed Link: | VENTOLIN HFA at DailyMed |


See drug prices for VENTOLIN HFA

Recent Clinical Trials for VENTOLIN HFA
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Ohio State University | Phase 4 |
Nationwide Children's Hospital | Phase 4 |
Ziauddin University | Phase 1 |
US Patents and Regulatory Information for VENTOLIN HFA
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | BX | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||
Glaxosmithkline | VENTOLIN HFA | albuterol sulfate | AEROSOL, METERED;INHALATION | 020983-001 | Apr 19, 2001 | BX | RX | Yes | Yes | See Plans and Pricing | See Plans and Pricing | Y | See Plans and Pricing | ||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for VENTOLIN HFA
International Patents for VENTOLIN HFA
See the table below for patents covering VENTOLIN HFA around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
European Patent Office | 1287820 | Compositions d'aérosol (Aerosol compositions) | See Plans and Pricing |
Germany | 69233076 | See Plans and Pricing | |
Estonia | 9700280 | See Plans and Pricing | |
United Kingdom | 0017301 | See Plans and Pricing | |
Bulgaria | 98803 | See Plans and Pricing | |
Czech Republic | 292578 | Inhalátor, inhalační systém (Inhalator, inhalation system) | See Plans and Pricing |
>Country | >Patent Number | >Title | >Estimated Expiration |